<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04698824</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A03469-30</org_study_id>
    <nct_id>NCT04698824</nct_id>
  </id_info>
  <brief_title>Hypnosis in Internal Medecine</brief_title>
  <acronym>HypnoMedIn</acronym>
  <official_title>Hypnose en médecine Interne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe Hospitalier Mutualiste de Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Description of the short and long-term impact of hypnosis sessions for patient having&#xD;
      benefited from at least one hypnosis session in internal medicine at the french hospital&#xD;
      &quot;Groupe Hospitalier Mutualiste de Grenoble&quot;, with the help of a qualitative survey made by&#xD;
      phone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The practice of hypnosis has experienced a recent boom in medicine, with a multiplication of&#xD;
      its fields of action. Regarding internal medicine, the influence of the psyche on the immune&#xD;
      system makes the use of hypnosis particularly relevant for autoimmune diseases. Medically&#xD;
      unexplained symptoms (another important field of internal medicine) are also strongly&#xD;
      psychosomatic and thus susceptible to hypnosis. The hypothesis is thus made that hypnosis can&#xD;
      bring multiple benefits to internal medicine patients.&#xD;
&#xD;
      The main objective of this study is to describe the short and long-term impact of hypnosis&#xD;
      sessions for patient having benefited from at least one hypnosis session in internal medicine&#xD;
      at the french hospital &quot;Groupe Hospitalier Mutualiste de Grenoble&quot;, with the help of a&#xD;
      qualitative survey made by phone.&#xD;
&#xD;
      Moreover retrospective medical data concerning these patients will be collected to determine&#xD;
      their medical history, their main symptoms et reasons to use hypnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of the short and long-term impact of hypnosis sessions thanks to a qualitative phone survey</measure>
    <time_frame>Assessed only once. Phone call will be performed between march 2021 and June 2021</time_frame>
    <description>Improvement in symptoms and quality of life, assessed thanks to a qualitative phone survey by 5-levels Likert scales</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the reasons for patient satisfaction / dissatisfaction</measure>
    <time_frame>Assessed only once. Phone call will be performed between march 2021 and June 2021</time_frame>
    <description>Qualitative description by an open question in the phone survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of the characteristics of these patients and of the hypnosis sessions</measure>
    <time_frame>At inclusion</time_frame>
    <description>Patients'characteristics described in medical records</description>
  </secondary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Hypnosis</condition>
  <condition>Autoimmune Diseases</condition>
  <condition>Medically Unexplained Symptoms</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypnosis session</intervention_name>
    <description>At least one session of hypnosis in the internal medicine unit at the hospital &quot;Groupe Hospitalier Mutualiste de Grenoble&quot;</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients who had at least one hypnosis session in internal medicine at the&#xD;
        hospital &quot;Groupe Hospitalier Mutualiste de Grenoble&quot; between 08/28/2015 (date of the very&#xD;
        first hypnosis consultation in internal medicine) and 03/17/2020 (date of confinement due&#xD;
        to Covid19 in France)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consecutive patients who had at least one hypnosis session in internal medicine at&#xD;
             the hospital &quot;Groupe Hospitalier Mutualiste de Grenoble&quot; between 08/28/2015 (date of&#xD;
             the very first hypnosis consultation in internal medicine) and 03/17/2020 (date of&#xD;
             confinement due to Covid19 in France)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient who had a hypnosis session, but who is not followed for a pathology in&#xD;
             internal medicine or in internal medicine with a pneumological orientation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxime LUGOSI, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Grenoble Alpes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maxime LUGOSI, PhD</last_name>
    <phone>04 76 76 37 07</phone>
    <email>mlugosi@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mélanie ARNAUD</last_name>
    <email>marnaud3@chu-grenoble.fr</email>
  </overall_contact_backup>
  <reference>
    <citation>Lugosi M, Sacré K, Lidove O, Chauveheid MP, Brihaye B, Laissy JP, Chauchard M, Papo T. [Long-term follow-up of a French cohort of retroperitoneal fibrosis]. Rev Med Interne. 2013 Oct;34(10):591-9. doi: 10.1016/j.revmed.2013.02.002. Epub 2013 Mar 14. French.</citation>
    <PMID>23498668</PMID>
  </reference>
  <reference>
    <citation>Lugosi M, Alberti C, Zahar JR, Garrouste M, Lemiale V, Descorps-Desclère A, Ricard JD, Goldgran-Tolédano D, Cohen Y, Schwebel C, Vésin A, Timsit JF, Azoulay E. Aspergillus in the lower respiratory tract of immunocompetent critically ill patients. J Infect. 2014 Sep;69(3):284-92. doi: 10.1016/j.jinf.2014.04.010. Epub 2014 Jun 9.</citation>
    <PMID>24924557</PMID>
  </reference>
  <reference>
    <citation>Tolsma V, Schwebel C, Azoulay E, Darmon M, Souweine B, Vesin A, Goldgran-Toledano D, Lugosi M, Jamali S, Cheval C, Adrie C, Kallel H, Descorps-Declere A, Garrouste-Orgeas M, Bouadma L, Timsit JF. Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile. Chest. 2014 Nov;146(5):1205-1213. doi: 10.1378/chest.13-2618.</citation>
    <PMID>25033349</PMID>
  </reference>
  <reference>
    <citation>Günther SC, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vésin A, Chautemps M, Styfalova L, Ruckly S, Timsit JF. Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study). Intensive Care Med. 2016 Nov;42(11):1753-1765. Epub 2016 Oct 12.</citation>
    <PMID>27734108</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>internal medicine</keyword>
  <keyword>survey</keyword>
  <keyword>qualitative</keyword>
  <keyword>impact of hypnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autoimmune Diseases</mesh_term>
    <mesh_term>Medically Unexplained Symptoms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

